SRTOY SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS

Watchlist

19.650
0.0000.00%

15min DelayClose Dec 18 16:00 ET

19.12BMarket Cap112.93P/E (TTM)

SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS Key Stats

According to the latest financial report of SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS, the latest earnings per share (TTM) for the company is 0.03. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: EUR

Quarterly

FCF

Interested in knowing about SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS's free cash flow? The latest report shows it as 188.10M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: EUR

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS shows that the company's current ratio is 2.14, indicating healthy liquidity.

Currency: EUR

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS, the quick ratio is 1.03, indicating that the company can meet its short-term debt obligations.

Currency: EUR

Quarterly

ROE

Want to learn more about the financial health of SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS? The latest ROE figure is 0.65%, indicating that the company has stable profitability.

Currency: EUR

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS, the total asset return on investment (ROA) is 0.32%.

Currency: EUR

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS's latest financial report to see how their gross margin is doing - currently at 42.04%.

Currency: EUR

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.1 ORD SHS, the net profit margin is 4.01%, which is a good sign for its profitability.

Currency: EUR

Quarterly

Trending US Stocks